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ABSTRACT 
 
THE ROLE OF G-QUADRUPLEX RNA MOTIF IN FRAGILE X SYNDROME 
 
 
By 
Yang Zhang 
May 2014 
 
Thesis supervised by Dr. Mihaela-Rita Mihailescu 
Fragile X syndrome (FXS), the most common cause of inherited mental 
impairment, is caused by the loss of expression of the fragile X mental retardation protein 
(FMRP). As an RNA binding protein, FMRP has been proposed to regulate the transport 
and translation of specific message RNA (mRNA). It has been reported that FMRP uses 
its RGG box domain to bind mRNA targets that form a G-quadruplex structure, structure 
believed to be important for FMRP recognition of at least a subclass of its mRNA targets. 
We have hypothesized that the interaction of FMRP with selected relevant mRNA targets 
occurs in a G-quadruplex dependent manner. By analyzing the structure of two FMRP in 
vivo mRNA targets, Shank1 mRNA and BASP1 mRNA, and their interactions with 
FMRP, we showed a high-affinity interaction between Shank1 RNA G-quadruplex and 
FMRP. The other G-quadruplex forming mRNA BASP1, however, interacts with FMRP 
using other structural elements.  
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CHAPTER 1: INTRODUCTION 
1.1 Fragile X syndrome 
Fragile X syndrome (FXS) is the most common cause of inherited mental 
impairment, affecting ~1 in 4000 males and ~1 in 8000 females (1). FXS patients suffer 
from multiple behavioral problems including cognitive impairments, impaired visuo-
spatial processing, hyperactivity, anxiety, and autism in a number of cases (2). FXS is 
caused by the loss of expression of the fragile X mental retardation protein, due to an 
unstable expansion of a cytosine-guanine-guanine (CGG) trinucleotide repeat and its 
subsequent hypermethylation in the 5’-untranslated region (5’-UTR) of the fmr1 gene (3, 
4). When the CGG repeats exceed 230, they cause the transcriptional silencing of the 
fmr1 gene and, consequently, the loss of the fragile X mental protein (FMRP). There is 
no specific treatment for fragile X syndrome. 
1.2 Fragile X mental retardation protein  
FMRP is produced in many tissues, being most abundantly expressed in brain and 
testes (5). In neurons, FMRP is present in the cell body as well as at the synapses (6). As 
a messenger RNA (mRNA) binding protein, FMRP contains two types of RNA-binding 
motifs: two K-homology (KH) domains and one arginine-glycine-glycine rich region 
(RGG) box (Figure 1.1). Additionally, it contains a nuclear localization signal (NLS) at 
the N-terminal and a nuclear export signal (NES) at its C-terminal, which allow FMRP to 
shuttle between the nucleus and cytoplasm (7, 8). FMRP has been proposed to act as a 
transport and translation regulator, functioning in downstream pathway of mGluRs and 
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upstream of local protein synthesis (43). FMRP binds its mRNA targets in the nucleus 
and transports them as part of larger ribonucleoproteins to dendrites (43). FMRP 
normally represses the translation of its mRNA targets, but its repression is released once 
FMRP is dephosphorylated upon mGluR activation, allowing the burst of local protein 
synthesis (Figure 1.2 A) (43). In fragile X syndrome neurons, however, a subset of 
dendritic proteins synthesis is constitutively elevated due to the lacking of FMRP even in 
the absence of mGluR activation (Figure 1.2 B).  
FMRP mRNA that contains 17 exons has been shown to undergo the post-
translational modifications of arginine methylation, phosphorylation and alternative 
splicing (9, 10, 11), resulting potentially in 20 FMRP isoforms. However, only five of 
them have been found in various tissues (5, 12). The three highest molecular weight 
FMRP isoforms correspond to isoform 1 (ISO1), isoform 2 (ISO2) and isoform 3 (ISO3). 
Each of them contains all 17 exons but differs in the utilization of the splice acceptor sites 
 
Figure 1.1 A schematic representative of the full-length FMRP, showing the nuclear 
localization signal (NLS), the two K- homology domains (KH1 and KH2), the nuclear 
export signal (NES) and the RGG box (RGG). It also illustrates the three heaviest 
molecular weight isoforms, ISO1, ISO2 and ISO3. The phosphorylation at serine 500 
is the main phosphorylation site of FMRP (highlighted in red). Adapted from (41). 
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of exon 15. ISO1, the longest FMRP isoform, is spliced out to form ISO2 and ISO3. 
While all three FMRP isoforms maintain the NLS, KH1, KH2, NES and the RGG box 
domain, the main phosphorylation site being spliced out in the isoforms ISO2 and ISO3 
(13, 14) (Figure 1.1). The investigated isoforms in this study are ISO1 and its 
phosphorylated mimic named ISOP. ISOP is a S500D mutant in which serine 500 was 
mutated to aspartic acid, as it has been shown that the phosphorylation at serine 500 is the 
main phosphorylation site of FMRP (15). Unphosphorylated FMRP has been shown to be 
associated with actively translating polyribosomes while the phosphorylated form 
interacts with stalled ribosomes, suggesting that phosphorylation plays a role in 
modulating the translation regulation function of FMRP (16). Employing these two 
 
 
Figure 1.2 Metabotropic glutamate receptor (mGluR) theory of fragile X syndrome. 
FMRP normally represses the translation of its mRNA targets, but its repression is 
released once FMRP is dephosphorylated upon mGluR activation, allowing the burst 
of local protein synthesis (a). In neurons lacking FMRP, however, a subset of 
dendritic proteins synthesis is constitutively elevated even in the absence of mGluR 
activation (b). Adapted from (43). 
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FMRP isoforms ISO1 and ISOP1, we aim to investigate if the posttranslational 
modification of phosphorylation modulates the FMRP translation regulator function by 
affecting its binding affinity to its G-quadruplex forming mRNA targets. As a regulator 
that controls the transport and translation of specific mRNA targets, it has been reported 
that FMRP uses its RGG box domain to bind mRNA targets that form G-quadruplex 
structures (12, 17, 19). 
1.3 G-quadruplex structures  
  DNA or RNA sequences rich in guanine content have high potential to fold into G 
quartets. A G quartet is formed by four guanine residues arranged in a planar 
configuration by Hoogsteen-type hydrogen bonds (20, 21, 22) (Figure 1.3). Several G 
quartet planar structures are able to stack onto each other to fold into a G-quadruplex 
structure. The G-quadruplex formation is dependent on the presence of cations lying 
within each G quartet plane or between planes. It has been reported that K+ and Na+ ions 
stabilize the G-quadruplex structure (23). It has been shown that DNA G-quadruplexes 
are over-represented in oncogene promoters, which are viewed as an emerging 
therapeutic target (42). Transcriptional repression achieved by stabilizing these G-
quadruplex structures located in the promoter region of specific genes could be a novel 
anti-cancer strategy. Given that RNA is single-stranded and that G-quadruplex formation 
doesn’t have to compete with hybridization to a complementary strand, RNA G-
quadruplexes are generally more stable in the folded form than DNA G-quadruplexes 
(46). The existence of RNA G-quadruplexes in vivo is more prevalent than the existence 
of G-quadruplexes in DNA (44). This secondary structure has been most found in 
mRNAs’ untranslated region (UTR), 3’ UTR or 5’ UTR, which are known to be involved 
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in translational regulation, particularly for growth factors, transcription factors and onco-
proteins, implying that G-quadruplex play a role in gene expression regulation at the 
mRNA level (45, 24, 25). 
1.4 FMRP recognition of its mRNA targets  
Though it has been shown that the FMRP participates in the post-transcriptional 
control of gene expression, the exact mechanisms by which FMRP recognizes its targets 
and exerts its translation regulator function are not known. It is believed that the G-
quadruplex structure plays an important role in the FMRP recognition of at least a 
subclass of its mRNA targets. We have hypothesized that the interaction of FMRP with 
its mRNA targets occurs in a G-quadruplex dependent manner. A crucial question 
remains: is the recognition of G-quadruplex essential for fragile X mental retardation 
protein function? By analyzing FMRP’s interactions with different mRNA targets, in this 
study we aim to understand the principles of recognition between FMPR and its mRNA 
targets. Accordingly, we selected two FMRP in vivo mRNA targets to characterize their 
structures and interactions with FMRP. 
 
Figure 1.3 A G quartet is formed by four guanine residues with Hoogsteen-type 
hydrogen bonds. These planar G quartets stack on top of each other to form a G-
quadruplex structure further stabilized by K+ ions. Adapted from (42). 
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1.5 Shank1 mRNA 
The postsynaptic density (PSD) is a protein network attached to the postsynaptic 
membrane of excitatory synapses. It serves to cluster cell adhesion molecules, to recruit 
signaling proteins, and anchor these components to the microfilament-based cytoskeleton 
in dendritic spines (31, 32, 33). As a translation regulator, FMRP has been reported to 
locally control the synthesis of proteins in dendrites, such as components of the PSD (34, 
35). Specifically, some postsynaptic proteins are affected by the loss of FMRP. As one of 
the PSD components, SH3 and multiple ankyrin repeat domains proteins (Shank) regulate 
the size and shape of dendritic spines because of their capacity to directly interact with 
many different PSD components, and represent master scaffold proteins of the PSD (31). 
Due to their effect on spine morphology, altered translational regulation of Shank1 
transcripts may contribute to the FXS pathology (36). Increased Shank1 levels have been 
found in PSD fractions obtained from FMRP-deficient mice (37). Schütt et al. (37) have 
also shown that Shank1 mRNA is an in vivo FMRP target. Molecular evidence has shown 
that FMRP represses translation of Shank1 mRNA via its 3’ UTR. In this study, we have 
identified G-quadruplex-forming sequences located in the 3’ UTR of human Shank1 
mRNA. FMRP may repress Shank1 expression levels via its interaction with these G-
quadruplex-forming sites. We hypothesize that the interaction of FMRP with Shank1 
mRNA 3’ UTR is dependent upon the recognition of G-quadruplex structure. Two G-
quadruplex forming sequences in Shank1 RNA 3’ UTR were predicted by QGRS mapper 
software (Materials and Method section), named Shank1a RNA and Shank1b RNA in our 
study. It’s interesting to note that these two sequences are located immediately adjacent 
to each other in Shank1 RNA.  
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1.6 BASP1 mRNA 
BASP1 mRNA encodes for the brain abundant, membrane attached signal protein 1 
(BASP1), which is expressed throughout the brain, with localization to the synaptic 
terminals, dendritic spines, and thin nerves fibers associated with synaptic vesicles, 
presynaptic and postsynaptic membranes and microtubes (38). BASP1 appears to be 
important for neuronal sprouting and plasticity, which are abnormal in FXS (39). It was 
reported that BASP1 was differentially expressed between fmr1 knock-out and wild type 
synapses in mice (40). Furthermore, BASP1 mRNA was identified as a potential FMRP 
mRNA target and predicted to form an intramolecular G-quadruplex recognized by 
FMRP RGG box (17). Accordingly, we analyzed the human BASP1 RNA by QGRS 
mapper to identify the sequences that most likely form G-quadruplex structures. Two 
selected sequences located in the coding region and 5’ UTR, respectively, were identified 
and were named accordingly as BASP1-Coding and BASP1-5’ UTR. 
1.7 Specific aims of this study 
We have hypothesized that the interactions of FMRP with its mRNA targets, Shank1 
RNA and BASP1 RNA, are dependent on G-quadruplex structure. To investigate the 
principles of recognition between FMRP and its target mRNAs, we aim to: (i) examine 
the existence of G-quadruplex structure in these selected mRNA targets and (ii) analyze 
their interactions with FMRP. Accordingly, this study which employs biochemical and 
biophysical methods to analyze the structure of these two FMRP in vivo mRNA targets 
and their interactions with FMRP, has the following specific aims: 
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Specific Aim I: Characterization of the secondary structure of Shank1 mRNA and 
BASP1 mRNA. 
 
Specific Aim II: Characterization of the interactions of FMRP with Shank1 mRNA and 
BASP1 mRNA. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 G-quadruplex structure prediction  
 Quadruplex forming G-Rich Sequences (QGRS) mapper, a web-based server for 
predicting G-quadruplexes in nucleotide sequences, was used to identify G-rich 
sequences in the human Shank1 3’UTR RNA and BASP1 RNA 
(http://bioinformatics.ramapo.edu/QGRS/index.php). The sequences with highest G 
score, which indicates a high potential to form G-quadruplex structures, were selected 
and named Shank1a RNA, Shank1b RNA, BASP1-5’UTR RNA and BASP1-Coding 
RNA, respectively (Table 2.1).  
2.2 Synthesis of RNA in vitro 
Shank1a RNA, Shank1b RNA, BASP1-5’UTR RNA and BASP1-Coding RNA 
were synthesized using the designed synthetic DNA templates (TriLink BioTechnologies, 
Inc.) by T7 RNA polymerase driven in vitro transcription reactions (Table 2.1). The T7 
RNA polymerase was produced in-house. The synthetic DNA templates were purchased 
from TriLink BioTechnologies, Inc. The produced oligonucleotides were purified by 20% 
Table 2.1 The synthetic RNA oligonucleotides by in vitro transcription. 
 
Shank1a 5’ GGGGUUGGGGAGGGUGUAGGGGGUGGGG 3’ 
Shank1b 5’ GGGGAGGAGAGGUCGGGGUGGGGAGUGGGG 3’ 
BASP1-5’ UTR 5’ GGGCAGGAAGGGGAGGGGGAGCGAG 3’ 
BASP1-Coding 5’ GGGCAAGGCCGAGGAGAAGG 3’ 
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8 M urea denaturing polyacrylamide gel electrophoresis and electrophoretic elution, 
followed by extensive dialysis against 10 mM cacodylic acid, pH 6.5. 
The fluorescencently labeled single stranded oligonucleotides were constructed by 
replacing one of the adenines in the original RNA sequences with its fluorescent analog 
2-aminopurine (2AP), and were chemically synthesized by Dharmacon, Inc. The adenine 
replaced in each RNA sequence is indicated in red in Table 2.2. 
 
 All DNA templates and 2-aminopurine labeled RNAs were re-suspended in sterile 
deionized water before using. All oligonucleotides were annealed by heating in boiling 
water at 95 °C, followed by slow cooling at room temperature. 
2.3 FMRP RGG box peptide synthesis 
The FMRP RGG box peptide was chemically synthesized and purified by the 
Peptide Synthesis Unit at the University of Pittsburgh, Center for Biotechnology & 
Bioengineering. 
Table 2.2 The fluorescently labeled RNA oligonucleotides. The replaced adenines 
with 2-aminopurine were highlighted in red.  
 
Shank1a (2AP) 5’ GGGGUUGGGGAGGGUGUAGGGGGUGGGG 3’ 
Shank1b (2AP) 5’ GGGGAGGAGAGGUCGGGGUGGGGAGUGGGG 3’ 
5’ GGGGAGGAGAGGUCGGGGUGGGGAGUGGGG 3’ 
BASP1-5’ UTR (2AP) 5’ GGGCAGGAAGGGGAGGGGGAGCGAG 3’ 
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2.4 Expression and purification of recombinant FMRP ISO1 and ISOP 
The pET-21a-FMRP plasmid, encoding ISO1 fused with a C-terminal 6x histidine 
tag, was a gift from Dr. Bernhard Laggerbauer (47). Sara Katrancha, a former 
undergraduate in the Mihailescu laboratory, designed a phosphorylated mimic of the 
FMRP ISO1, ISOP, in which serine 500 was replaced by aspartic acid to mimic 
phosphorylation on serine 500 (15). The pET-21a-FMRP ISOP plasmid was produced by 
GenScript USA, Inc. To recombinantly express, purify and dialyze FMRP ISOP, we used 
the protocol previously developed in our laboratory for the expression of FMRP ISO1 
(18). Briefly, each plasmid was transformed into the Rosetta 2(DE3) pLysS E. coli cell 
line, cells were incubated at 37 °C, 250 rpm until an OD600 of 0.8 – 1.0, and target protein 
expression was induced by adding isopropyl β-D-1-thiogalactopyranoside to 1 mM, and 
incubating the cells at 25 °C, 250 rpm for 12 h. Cells were harvested and lysed, and each 
FMRP isoform was purified using Ni-NTA Superflow resin (Qiagen) as described in 
(18). Purified proteins were concentrated using dialysis tubing filled with polyethylene 
glycol (PEG) 20,000 (48). The two isoforms were dialyzed into a buffer devoid of K+ and 
Na+, suitable for the analysis of their binding activity to G-quadruplex forming mRNAs. 
Dialysis occurred in the presence of 5% glycerol and 1 mM EDTA with the gradual 
removal of imidazole, as described in (18). The concentration of the FMRP isoforms was 
determined by A280 using the same molar extinction coefficient of 46,370 M
-1cm-1 for 
ISO and ISOP (49, 50). Successful production of each FMRP isoform was analyzed using 
10 % tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and visualized using Coomassie blue. 
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2.5 UV spectroscopy thermal denaturation 
UV thermal denaturation curves were obtained using a Varian Cary 3E UV-
Visible Spectrophotometer with a Peltier temperature control cell holder. Samples were 
annealed prior to performing the experiments in the presence of various concentrations of 
KCl in 10 mM cacodylic acid, pH 6.5. Samples and reference cells were covered with 
200 μL of mineral oil to prevent evaporation at high temperature. The RNA samples were 
heated from 25 to 95°C at a rate of 0.2°C/min, and absorbance points were recorded at 
every 1°C at 295 nm, wavelength identified to be most sensitive to G-quadruplex 
dissociation (30). To determine if these G-quadruplex forming RNAs adopt an 
intermolecular or intramolecular conformation, the melting temperature of the G-
quadruplex structure was determined at different RNA concentrations. 
The hypochromic transition of the G-quadruplex dissociation in Shank1a RNA 
and Shank1b RNA was identified and fitted with Equation 2.1, which assumes an 
independent two state model:  
 
where AU and AF respectively represent the absorbance of the unfolded and native G-
quadruplex structures, and R is the gas constant. 
2.6 Circular dichroism (CD) spectroscopy 
The CD spectra were recorded on a Jasco J-810 spectropolarimeter at 25°C. The 
G-quadruplexes formation in 10 mM cacodylic acid, pH 6.5, was monitored as increasing 
𝐴(𝑇) =
𝐴𝑈+ 𝐴𝐹𝑒
−𝛥𝐻0
𝑅𝑇 𝑒
𝛥𝑆0
𝑅
𝑒
−𝛥𝐻0
𝑅𝑇 𝑒
𝛥𝑆0
𝑅 + 1
 
Equation 2.1 
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amounts of KCl were titrated from a 2 M stock solution to a final concentration of 150 
mM. The spectra were measured between 200 and 350 nm and corrected for solvent 
contributions and dilutions. Each spectrum was scanned seven times with 1 s response 
time and a 2 nm bandwidth. For the binding studies, increasing amounts of the RGG 
peptides (0–80 µM) were titrated into a fixed concentration of RNA (10 µM) in 10 mM 
cacodylic acid, pH 6.5, and 25 mM KCl.  
2.7 1H-NMR spectroscopy 
The one dimensional 1H NMR spectra of the RNA oligonucleotides were acquired 
at 25ºC on a 500 MHz Bruker AVANCE spectrometer. Water suppression was carried 
out by using the Watergate pulse sequence (51). Maximum concentrations of RNA 
samples (~ 200 μM) were prepared in 10 mM cacodylic acid buffer, pH 6.5, in a 90% 
H2O/10% D2O ratio. G-quadruplex formation was monitored by titrating increasing 
concentrations of KCl from a 2 M stock to each sample. Annealed samples were prepared 
by removing the RNA samples from the NMR tube followed by 5 minutes boiling and 10 
minutes cooling to 25 °C. 
2.8 Native polyacrylamide gel electrophoresis (PAGE) and electromobility gel shift 
assays (EMSA) 
10 µM of RNA samples in the presence of various concentrations of KCl were 
annealed by boiling for 5 minutes followed by cooling down at room temperature for 10 
minutes, prior to their use in native gel electrophoresis. The 20% native gels in 0.5X 
Tris/Borate/EDTA buffer were run at 4ºC, 85 V for 6 h using vertical gel apparatus and 
visualized by UV shadowing at 254 nm using an AlphaImager (AlphaInnotech, Inc.).  
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To examine the effect of the FMRP RGG domain binding, a total volume of 15 
µL RNA in the presence of desired concentrations of KCl was prepared for each RNA 
sample, prior to the 5 minutes annealing. Synthetically produced FMRP RGG peptide 
was added to the RNA in various ratios and incubated for 20 minutes at room 
temperature. 1 µL of loading buffer (15% glycerol in 10X TBE buffer) was added to each 
sample after incubation. The samples were run on 20% native polyacrylamide gels 
(containing 5 mM KCl) in 0.5X Tris/Borate/EDTA buffer in the presence of 5 mM KCl 
at 4ºC, 85 V for 6 hours. Electrophoretic motilities of RNA sample were visualized using 
UV-shadowing at 254nm using an AlphaImager (AlphaInnotech, Inc.). 
2.9 Fluorescence spectroscopy 
Steady-state fluorescence spectroscopy measurements of Shank1a RNA binding 
with the FMRP RGG box were performed on a Horiba Jobin Yvon Fluoromax-3 
equipped with a temperature controller set up to 23 °C. All the other fluorescence 
spectroscopy measurements were performed on a Horiba Jobin Yvon Fluoromax-4 
spectrofluorometer at room temperature in the range of 24.5 – 27 °C. The excitation 
wavelength was set at 310 nm and the emission spectrum was recorded in the range of 
330 – 450 nm. The bandpass for excitation and emission monochromators were both set 
to 5 nm. Increasing concentrations of the FMRP RGG peptide or the FMRP isoforms 
were titrated in 50 nM increments to a fixed 200 nM RNA. 1 μM of HCV peptides or 
BSA was added into the RNA sample before titrating RGG peptides and isoforms, 
respectively. The emission values were corrected and normalized to free RNA 
fluorescence intensity at 371 nm. Each binding experiment was performed in triplicate. 
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The binding dissociation constant Kd, was determined by fitting the binding curves to the 
equation: 
where IF and IB represents the steady-state fluorescence intensities of the free and bound 
RNA, [RNA]t is the total concentration of RNA and [P]t is the total RGG box peptide or 
FMRP isoform concentration. The reported Kd value is the average from triplicates with 
the highest error in these three trails.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equation 2.2 
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CHAPTER 3: CHARACTERIZATION OF THE SHANK1 RNA G-
QUADRUPLEX STRUCTURES 
3.1 Characterization of the Shank1a RNA 
It has been reported that FMRP locally controls the synthesis of proteins in 
dendrites, such as components of the postsynaptic density (PSD) (34, 35). SH3 and 
multiple ankyrin repeat domains proteins (Shank), one of the PSD components, regulate 
the size and shape of dendritic spines and represent master scaffold proteins of the PSD 
(31). Shank1 mRNA has been identified as an in vivo FMRP target, supported by the 
                 
 
Figure 3.1 The 1H NMR spectra of the Shank1a RNA shows the existence of the G-
quadruplex structure reflected by the imino proton resonances from 10 – 12 ppm. 
There is no Watson-Crick base pair resonances from 12 – 14.5 ppm observed in the 
spectra. Increasing the KCl concentration doesn’t lead to any conformation change in 
the Shank1a RNA. 
50 mM KCl 
25 mM KCl 
10 mM KCl 
0 mM KCl 
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molecular evidence that FMRP represses translation of Shank1 mRNA via its 3’ UTR 
(37). We hypothesize that the interaction of FMRP with Shank1 mRNA 3’ UTR is 
dependent upon the recognition of G-quadruplex structure. Two G-quadruplex forming 
sequences in Shank1 RNA 3’ UTR were identified and named Shank1a RNA and 
Shank1b RNA in our study. First, we performed the analysis of the Shank1a RNA, one of 
the selected G-quadruplex forming sequences in Shank1 RNA. 
To examine the existence of G-quadruplex structures in the Shank1a mRNA, we 
first performed 1H NMR spectroscopy experiments, monitoring the imino proton 
resonance region. Resonances located between 12-14.5 ppm report upon the formation of 
guanine and uracil imino protons involved in Watson-Crick base-pairs, whereas those 
from 10 – 12 ppm correspond to the guanine imino protons involved in the formation of 
G-quadruplex structures (26). Spectra were acquired for the Shank1a RNA sample in the 
presence of various concentrations of KCl. Figure 3.1, (blue spectrum) indicates that even 
in the absence of KCl, a G-quadruplex structure is formed in Shank1a RNA, as reflected 
by the presence of the broad resonance in the region 10-12 ppm. In the presence of 10 
mM KCl, a few resonances on the broad envelope centered around 11 ppm become more 
refined, indicating the structure stabilization (Figure 3.1, red spectrum). No additional 
changes were observed once the KCl concentration was increased to 25 and 50 mM 
(Figure 3.1, green and purple spectra). No resonances are observed in the region 12-14.5 
ppm, indicating that Shank1a mRNA does not form alternate structures involving 
Watson-Crick base pairs. Taken together the 1H NMR spectroscopy results indicate that 
Shank1a RNA forms a G-quadruplex structure even at the 0 mM KCl, structure further 
stabilized by the presence of K+ ions. The G-quadruplex imino proton resonances 
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observed are on a broad envelope, indicating a dynamic exchange between 
conformations. 
 To examine the conformations of the G-quadruplex formed in Shank1a RNA, we 
performed native polyacrylamide gel electrophoresis in the presence of increasing KCl 
concentrations, in the range 0-50 mM (Figure 3.2). Two bands are present in the absence 
of KCl (Figure 3.2, lane 1), indicating the co-existence of alternate conformations. Upon 
increasing the KCl concentration the equilibrium between the two conformations shifts, 
as reflected by the decrease in the intensity of the lower migrating band.   
 
 The QGRS mapper software predicts a single G-quadruplex structure in the 
Shank1a RNA, which consists of four G4 groups (GGGG)s (underlined in Table 3.1), a 
longer loop and two short loops. However, upon the further analysis of this sequence, we 
noticed that two alternate conformations could form within this sequence. This dynamic 
conformation change is due to a single guanine shift between the third G4 group and its 
adjacent short loop (highlighted in red in Figure 3.3). In conformation I (Table 3.1 I and 
Figure 3.3 I), the guanine located in position 19 is part of the third G4 group and the 
                           
Figure 3.2 The native polyacrylamide gel electrophoresis of 15 μM Shank1a RNA at 
various KCl concentrations: 0 mM (lane 1), 5 mM (lane 2), 10 mM (lane 3), 25 mM 
(lane 4) and 50 mM (lane 5). Two bands at 0 mM KCl indicates there are alternate 
conformations coexisting in the Shank1a RNA (arrows). 
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guanine in position 23 forms a short loop along with the uracil in position 24. In 
conformation II (Table 3.1 II and Figure 3.3 II), the guanine in position 19 is involved in 
a long loop and the guanine 23 is now part of the third G4 group. The native 
polyacrylamide gel electrophoresis results (Figure 3.2) support the existence of two 
distinct G-quadruplex conformations. However, we cannot assign the upper or lower 
band to conformations I or II, respectively. 
Table 3.1 The two different conformations of the four-plane Shank1a RNA G-
quadruplex structure, due to a guanine shift from the third G-quartet in conformation 
(I) to the short loop in conformation (II).  
 
I                                                         19            23 
5’ GGGGUUGGGGAGGGUGUAGGGGGUGGGG 3’ 
         1                2                                3                4 
II 5’ GGGGUUGGGGAGGGUGUAGGGGGUGGGG 3’ 
         1                2                                   3             4  
 
                  
Figure 3.3 The two different conformation predictions of the Shank1a RNA G-
quadruplex structure based on Table 4.1. There is dynamic equilibrium between 
conformation (I) and (II). The guanines highlighted in red shift between these two 
conformations. 
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 To obtain further information about the fold of the Shank1a RNA G-quadruplex 
structures we performed CD spectroscopy experiments in the presence of different 
concentrations of KCl. At 0 mM KCl, a negative band was observed at 240 nm and a 
positive one at 265 nm, the typical CD signature of a parallel G-quadruplexes (27, 28) 
(Figure 3.4, yellow spectrum). Once the KCl concentration was increased to 25 mM (blue 
spectrum), the intensities of both the positive and negative bands increased significantly, 
indicating that KCl facilitates the stabilization of the G-quadruplex structures in the 
Shank1a RNA. At higher concentrations 50 mM (red spectrum) and 100 mM (green 
spectrum), the intensities of these bands increased further, but not as much as from 0 mM 
to 25 mM KCl. Taken together the 1H NMR spectroscopy, CD spectroscopy and native 
                    
Figure 3.4 The CD spectra of 10 μM Shank1a RNA prepared in 10 mM cacodylic 
acid at various KCl concentrations showing the presence of a parallel G-quadruplex 
structures stabilized by KCl. 
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gel electrophoresis experiments, indicate that Shank1a RNA forms two alternate parallel 
G-quadruplex structures, one of which is further stabilized by the presence of K+ ions. 
 To determine if the G-quadruplex structures formed by Shank1a RNA are 
intermolecular or intramolecular we employed UV spectroscopy thermal denaturation 
experiments. 
For intermolecular G-quadruplexes, the melting temperature, Tm, depends on the 
RNA concentration, CT : 
where n is the number of strands, R is the gas constant and ΔH0vH and ΔS0vH are the Van’t 
Hoff thermodynamic parameters (Equation 4.1). For intramolecular conformations, n 
                    
 
Figure 3.5 The UV thermal denaturation profiles of the Shank1a RNA in the presence 
of 10 mM cacodylic acid, pH 6.5, and 2.5 mM KCl at various RNA concentrations.  
 
              
 
Equation 4.1 
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equals to 1. The melting temperature Tm is therefore independent of the total RNA 
concentration CT (Equation 4.2). 
 Several Shank1a RNA concentrations in the range 5-25 μM in 10 mM cacodylic 
acid, pH 6.5, 2.5 mM KCl were thermally denatured and the absorbance changes were 
monitored at 295 nm, wavelength shown to be most sensitive to G-quadruplex 
dissociation (30). 
As seen in Figure 3.5, at all RNA concentrations investigated, a single 
hypochromic transition is present in the UV thermal denaturation profile of Shank1a 
RNA, typical of G-quadruplex structure unfolding. The melting temperature does not 
                                             
Equation 4.2 
                    
 
Figure 3.6 The melting temperatures of the Shank1a RNA G-quadruplex in the 
presence of 2.5 mM KCl was plotted versus the RNA concentrations. It shows that the 
melting temperature is independent on the RNA concentrations. 
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change significantly upon changing the RNA concentration (Figure 3.5), indicating that 
the G-quadruplex structure formed by Shank1a RNA is intramolecular.   
To further quantitatively measure the melting temperatures of the Shank1a RNA, 
we identified and fitted the hypochromic transitions at various RNA concentrations into 
an independent two-state model mentioned in the Materials and Methods section 
(Equation 2.1). The calculated melting temperatures of each transition at different RNA 
concentrations were plotted against the RNA concentration (Figure 3.6) to show that the 
melting temperature of the Shank1a RNA G-quadruplex is independent of the RNA 
concentration.  Its melting temperature in the presence of only 2.5 mM KCl is 73 °C, 
indicating a highly stable G-quadruplex structure. 
Taken together the biophysical and biochemical analysis of Shank1a RNA, we 
found that it adopts very stable parallel G-quadruplex structures that forms in an 
intramolecular manner. Additionally, there is equilibrium between alternate 
conformations existing in this G-quadruplex forming sequence, one of which is further 
stabilized by the presence of K+ ions. 
3.2 Characterization of the Shank1b RNA 
 
We next performed the analysis of the other predicted G-quadruplex forming 
sequence, Shank1b RNA, which was also identified in Shank1 3’ UTR RNA. To examine 
if a G-quadruplex forms also in Shank1b RNA, we monitored the imino proton resonance 
region by 1H NMR spectroscopy. Spectra of the Shank1b RNA were recorded in the 
presence of different concentrations of KCl. The broad resonance located in the 10 -12 
ppm region indicates that a G-quadruplex structure is formed in the Shank1b RNA even 
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in the absence of KCl (Figure 3.7, blue spectrum). In the presence of 10 mM KCl, the 
more refined resonances on the broad envelope centered around 11.2 ppm suggests an 
enhanced stability of G-quadruplex structure (Figure 3.7, red spectrum). No additional 
changes were observed once the KCl concentration was increased to 25 and 50 mM 
(Figure 4.10, green and purple spectra). No resonances were observed in the region 12 – 
14.5 ppm, indicating that Shank1b RNA doesn’t adopt alternate structures involving 
Watson-Crick base pairs. Taken together, the 1H NMR spectroscopy results suggest that 
Shank1b RNA forms a G-quadruplex structure even in the absence of KCl, its stability 
being further facilitated by the addition of K+ ions. The broad envelope of the G-
 
 
Figure 3.7 The 1H NMR spectra of the Shank1b RNA shows the existence of the G-
quadruplex structure reflected by the imino proton resonances from 10 – 12 ppm. 
There are no Watson-Crick base pair resonances from 12 – 14 ppm observed in the 
spectra. 
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quadruplex imino proton resonances indicates a dynamic exchange between 
conformations.  
 To examine the conformation of the Shank1b RNA G-quadruplex we employed 
native polyacrylamide gel electrophoresis in the presence of increasing KCl 
concentrations, in the range 0 – 50 mM, (Figure 3.8). Two bands are presents in the 
absence of KCl, indicating the co-existence of alternate conformations in the Shank1b 
RNA (Figure 3.8, lane 1). The intensity of the lower band indicates that it corresponds to 
the dominant G-quadruplex conformation, whereas the diffuse upper band corresponds to 
an alternate conformation. Upon increasing the KCl concentration the two separated 
bands migrate as one single broad band which positions in the middle of them (Figure 
3.8, lane 2), indicating another conformation is formed in the presence of K+ ions. 
Equilibrium exists among these conformations in the presence of high concentration of 
KCl, as reflected by the very broad band at 25 and 50 mM KCl (Figure 3.8, lane 4 and 5).  
                  
 
Figure 3.8 The native polyacrylamide gel electrophoresis of 10 μM Shank1b RNA at 
various KCl concentrations: 0 mM (lane 1), 5 mM (lane 2), 10 mM (lane 3), 25 mM 
(lane 4) and 50 mM (lane 5). The arrows represents the two G-quadruplex 
conformations formed in the absence of KCl. 
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 By performing CD spectroscopy experiments in the presence of various 
concentrations of KCl, we obtained further information about the fold of the Shank1b 
RNA G-quadruplex. A negative band was observed at 240 nm and a positive one at 265 
nm in the absence of KCl, indicating that the Shank1b RNA forms parallel G-
quadruplexes (27, 28) (Figure 3.9, yellow spectrum). Once the KCl concentration was 
further increased, the intensities of these two bands were slightly increased, suggesting 
that K+ ions stabilize the G-quadruplex structures in the Shank1b RNA. Taken together 
the 1H NMR spectroscopy, CD spectroscopy and native gel electrophoresis experiments, 
indicate that Shank1b RNA forms alternate parallel G-quadruplexes, their overall 
stability being further stabilized by the presence of K+ ions.  
 Next, to determine if the formed G-quadruplex is intermolecular or 
intramolecular, we acquired the UV spectroscopy thermal denaturation profiles of the 
            
 
Figure 3.9 The CD spectra of 10 μM Shank1b RNA prepared in 10 mM cacodylic 
acid, pH 6.5, at various KCl concentrations shows a parallel G-quadruplex structures 
stabilized by KCl. 
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Shank1b RNA. Several Shank1b RNA concentrations in the range 5 – 25 μM were 
thermally denatured in the presence of 10 mM cacodylic acid, pH 6.5, and 10 mM KCl 
and the absorbance was monitored at 295 nm. We observed only a single hypochromic 
transition at all RNA concentrations investigated (Figure 3.10), typical for G-quadruplex 
structure unfolding. The melting temperature did not change significantly upon varying 
the RNA concentration (Figure 3.10), indicating that the Shank1b RNA G-quadruplex 
structure is intramolecular.  
 
 To quantitatively obtain the melting temperature of the Shank1b RNA, we 
identified and fitted the hypochromic transitions at investigated RNA concentrations into 
the two-state model with Equation 2.1 (Materials and Method section). In the presence of 
                 
 
Figure 3.10 The UV thermal denaturation profiles of the Shank1b RNA in the 
presence of 10 mM cacodylic acid and 10 mM KCl at various RNA concentrations. It 
shows no hypochromic transitions shift throughout the various RNA concentrations 
indicating the stability of the Shank1b RNA G-quadruplex is independent on RNA 
concentration. 
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10 mM KCl, the Shank1b RNA melting temperature is 76°C (Figure 3.11) versus Tm (73 
°C) of the Shank1a RNA at only 2.5 mM KCl, indicating that Shank1a RNA forms a 
more stable intramolecular G-quadruplex structure than Shank1b RNA. 
 
 
 
 
 
 
 
 
 
 
                 
                         
 
Figure 3.11 The melting temperatures of the Shank1b RNA G-quadruplex in the 
presence of 10 mM KCl was plotted versus the RNA concentrations. It shows that the 
melting temperature is independent on the RNA concentrations. 
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CHAPTER 4: CHARACTERIZATION OF THE INTERACTION BETWEEN 
SHANK1 RNA AND FMRP 
4.1 Characterization of the interactions between Shank1a RNA and FMRP 
 To determine the potential of the Shank1a RNA G-quadruplex to interact with the 
FMRP RGG box, we employed electromobility gel shift assays. Shank1a RNA samples 
were mixed with the FMRP RGG peptide at different ratios and to observe the effect of 
KCl on their interactions, similar samples were prepared in the presence of, 25 mM and 
50 mM KCl. At both of KCl concentrations the free Shank1a RNA migrates as two 
separated bands (Figure 4.1 lanes 1 and 4), corresponding to the two G-quadruplex 
conformations discussed in Chapter 3 (Figure 3.3). At a 1:1 ratio Shank1a RNA to FMRP 
RGG box the intensity of the upper band corresponding to the dominant G-quadruplex 
conformation was significantly reduced while the intensity of the lower band 
                      
Figure 4.1 EMSA of 15 μM Shank1a RNA in the presence of 25 mM KCl (lane 1, 2 
and 3) and 50 mM KCl (lane 4, 5 and 6) binding to the FMRP RGG box at different 
RNA: RGG ratios: 1:0 (lane 1 and lane 4), 1:1 (lane 2 and lane 5) and 1:2 (lane 3 and 
lane 6). It shows both conformation of the Shank1a RNA G-quadruplex bind to the 
FMRP RGG box. The upper band corresponding to the dominant G-quadruplex 
conformation has higher binding affinity with the RGG peptides (arrow). 
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corresponding to the alternative G-quadruplex conformation remains the same (Figure 
4.1 lanes 2 and 5).  The Shank1a RNA-FMRP RGG complex is not observed as a sharp 
retarded band in the gel due to the fact that the FMRP RGG box contains multiple 
positive charged arginine residues, affecting the overall charge of the complex. Thus, the 
binding event is monitored through the disappearance of the band corresponding to the 
free Shank1a RNA. At a 1:2 ratio Shank1a RNA to FMRP RGG box, both the upper and 
lower bands corresponding to the free Shank1a RNA vanished (Figure 4.1 lanes 3 and 6), 
with the concomitant appearance of a diffuse retarded band corresponding to the 
formation of the Shank1a RNA-FMRP RGG complex. These results suggest that 
although the FMRP RGG box binds with higher affinity to the predominant Shank1a G-
quadruplex conformation (upper band in lanes 1 and 4), both Shank1a RNA G-
quadruplex conformations can interact with the FMRP RGG box.  
 
To investigate the effect of the FMRP RGG box on inducing G-quadruplex 
unwinding we employed CD spectroscopy. Increasing amounts of the FMRP RGG box 
 
 
Figure 4.2 The CD spectra of 10 μM Shank1a RNA at various RNA: RGG ratios 
prepared in 10 mM cacodylic acid with 25 mM KCl (A) and 150 mM KCl (B). It 
shows that the FMRP RGG box induces the unwinding of the Shank1a RNA G-
quadruplex at high RNA: RGG ratios. 
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were titrated into a fixed concentration of Shank1a RNA in the presence of either 25 mM 
KCl or 150 mM KCl. At both 25 mM and 150 mM KCl, the free Shank1a RNA showed 
the unique parallel G-quadruplex signature (Figures 4.2 A and B grey spectrum). As 
increasing FMRP RGG ratios of 1:1, 1:2 and 1:4 (Figures 4.2 A and B green, orange and 
red spectra), were added into the sample the intensity of the positive band at 265 nm 
started to decrease. At high FMRP RGG ratios of 1:6 and 1:8 (Figure 4.2 A and B purple 
and blue spectra), the intensity of this band, as well as that of the negative band at 240 nm 
are significantly decreased, indicating the unwinding of the Shank1a RNA G-quadruplex 
structure by the RGG peptide. As expected, since the G-quadruplex structure is more 
stable in the presence of higher salt concentration the intensity of the band at 260 nm in 
the presence of 6 or 8 fold excess of FMRP RGG box, is higher in 150 mM KCl, versus 
25 mM KCl. 
To obtain quantitative information about the interactions between the FMRP RGG 
box and the Shank1a G-quadruplex we employed fluorescence spectroscopy. In these 
experiments we introduced a fluorophore into the Shank1a RNA sequence by replacing 
the adenine located at position 18 by its fluorescent analog 2-aminopurine (2AP) (Figure 
4.3). The steady-state fluorescence of 2AP is very sensitive to its surrounding 
environment, especially to stacking interaction. At its excited state, the fluorescent 
properties of the 2AP are strongly dependent on the electron transfer quenching process 
from guanine (52). As part of the loop in the formed G-quadruplex, the inserted 2AP at 
position 18 is predicted to have direct contact with the binding protein. Its fluorescence 
change therefore reports the interaction between the Shank1a RNA and the FMRP RGG 
box. The changes of the steady-state fluorescence signal of the 2AP labeled Shank1a 
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RNA upon titrating the FMRP RGG peptides were monitored at its emission wavelength 
371 nm. We observed a decrease in the fluorescence intensity after titrating the FMRP 
RGG box into the fluorescent Shank1a RNA, and the binding curve (Figure 4.4) was 
fitted with Equation 2.2 (Materials and Methods section) to obtain the dissociation 
constant of the Shank1 RNA: FMRP RGG box. The binding experiments were performed 
in triplicate, each binding curve being fitted independently, and the dissociation constant 
value of 68  9 nM was calculated as the average of the Kd values obtained from each 
experiment. It is interesting to note that even though it adopts a very stable G-quadruplex, 
the FMRP RGG box doesn’t bind tighter to the Shank1a RNA as compared with other 
RNAs investigated in Mihailescu laboratory. The difference is approximately two orders 
 
 
Figure 4.3 A fluorescently labeled 
Shank1a RNA was created by replacing 
the adenine at position 18 using its 
fluorescent analog 2-aminopurine 
(2AP). 
 
Figure 4.4 The FMRP RGG box was 
titrated into 200 nM of the fluorescently 
labeled Shank1a RNA in the presence of 
1 μM HCV peptides. The steady-state 
fluorescence data was fitted into the 
predicted model (Equation 2.2). The 
reported Kd value represents the 
average of three Kd values with the 
highest error in the triplicates. 
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of magnitude: Kd of 68 nM for the Shank1a RNA versus 0.7 nM for one of the G-
quadruplex forming RNAs human semaphorin RNA (19). One of the major causes could 
be the difference in the G-quadruplex surrounding loops, as Shank1a contains an 
extended loop of eight nucleotides, whereas in the case of the other RNAs, the loops 
contain between one to three nt. 
Once we confirmed the FMRP RGG box binding to the Shank1a G-quadruplex 
structure, we investigated the interactions of this RNA with the full-length FMRP, as the 
FMRP RGG box might behave differently in the context of the full-length protein. It has 
been shown that FMRP regulates the transport and translation of multiple messenger 
RNA targets involved in neuronal development (53-55). The mechanism of how FMRP 
exerts its translation regulator function is still under investigation, however, previous 
findings have shown that unphosphorylated FMRP is associated with actively translating 
polyribosomes and phosphorylated FMRP associates with stalled ribosomes, suggesting 
that phosphorylation might play a role in the FMRP translation regulation function (16).   
To mimic the phosphorylated form of full-length FMRP we have used the S500D 
mutant (15) in which serine 500 was mutated to aspartic acid (named FMRP ISOP in this 
study), as it has been shown that the phosphorylation at serine 500 is the main 
phosphorylation site of FMRP (15). In this study, we aim to investigate if the FMRP 
phosphorylation results in any potential binding affinity difference to the G-quadruplex 
forming Shank1a RNA.  
 We expressed the recombinant FMRP ISO1 (longest FMRP isoform) and ISOP in 
E. coli cells and purified them as described in the Materials and Methods section. The 
purity of FRMP ISO1 and ISOP was verified by performing SDS PAGE (Figure 4.5 A 
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and B). The selected eluate fractions were combined, concentrated and dialyzed 
extensively against a buffer of 5% glycerol and 1 mM EDTA with the gradual removal of 
imidazole. The final yield of FMRP ISO1 was 6.6 μM (sample prepared by the graduate 
student Snezana Stefanovic in Mihailescu laboratory), whereas for FMRP ISOP was 6.2 
μM. 
 To quantitatively measure the binding affinity of the Shank1a RNA G-quadruplex 
with the FMRP isoforms, we recorded the steady-state fluorescence emission of the 2AP 
labeled Shank1a RNA at 371 nm while titrating the respective FMRP protein isoform 
into the RNA samples. The experiments were performed in triplicate and the binding 
curves were fitted with Equation 2.2 to determine the dissociation constant of the 
                
Figure 4.5 The selected eluate fractions (lane 1 to lane 7) of the FMRP ISO1 (A) and 
ISOP (B) were run through the sodium dodecyl sulfate polyacrylamide gel with a 
protein ladder. It shows the purity of the expressed protein ISO1 and ISOP. 
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Shank1a RNA: FMRP ISO1 complex, Kd = 198  59 nM, and of the Shank1a RNA: 
FMRP ISOP complex, Kd = 281 ± 64 nM, respectively (Figures 4.6). These values are 
higher than the Kd =68  9 nM obtained for the Shank1a RNA: FMRP RGG box, likely 
due to a more complex structure of the full-length protein and therefore the reduced 
accessibility of the RGG box. The reduced binding affinity from the FMRP RGG box to 
the full-length FMRP isoforms was also observed for the other FMRP G-quadruplex 
forming RNA targets, such as Semaphorin 3F mRNA (Kd = (0.7  0.3)) nM for binding 
to the FMRP RGG box versus (104  11) nM for the FMRP ISO1) (19, 41). 
 However, the Kd values of the complexes formed by FMRP ISO1 and ISOP with 
Shank1a RNA are within error of each other, indicating that the posttranslational 
modification of phosphorylation does not modulate the translation regulator function of 
FMRP through different binding affinity to its G-quadruplex forming targets. The trend 
was also observed on a FMRP binding sequence (FBS), located in FMRP’s own mRNA, 
 
 
Figure 4.6 The FMRP ISO1 (A) and ISOP (B) were respectively titrated into 200 nM 
of the fluorescently labeled Shank1a RNA in the presence of 1 μM BSA. The steady-
state fluorescence data was fitted into the predicted model (Equation 2.2). The 
reported Kd value represents the average of three Kd values with the highest error in 
the triplicates. 
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binding to ISO1 and ISOP. Specifically, the FMRP ISO1 binding to FBS mRNA is not 
affected by the mutation of S500D (ISOP) that mimics the post-translational modification 
of phosphorylation (Kd = (120 ± 17) nM of FBS mRNA binding to ISO1 versus Kd = 
(130 ± 15) nM of ISOP) (56). 
4.2 Characterization of the interactions between Shank1b RNA and FMRP 
 Using EMSA we analyzed the interactions between the Shank1b RNA G-
quadruplex and the FMRP RGG box. To observe the effect of KCl on their interaction, 
the Shank1b RNA was incubated with the FMRP RGG box at different ratios in the 
presence of 10 mM and 25 mM KCl. The free RNA bands (Figure 4.7 lanes 1 and 5) 
correspond to the G-quadruplex formed in the Shank1b RNA. At 1:1 ratio Shank1b RNA 
to FMRP RGG box, the intensity of free RNA bands begins to decrease (Figure 4.7 lanes 
2 and 6). We observed a Shank1b RNA-FMRP RGG complex at 1:2 ratio Shank1b RNA 
                     
 
Figure 4.7 EMSA of 15 μM Shank1b RNA in the presence of 10 mM KCl (lane 1 to 
lane 4) and 25 mM KCl (lane 5 to lane 8) binding to the FMRP RGG box at different 
RNA: RGG ratios: 1:0 (lane 1 and lane 5), 1:1 (lane 2 and lane 6), 1:2 (lane 3 and lane 
7) and 1:4 (lane 4 and lane 8). The arrow indicates the band representing the complex 
formed by the Shank1b RNA and the FMRP RGG box. 
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to FMRP RGG (Figure 4.7 lanes 3 and 7) even though the corresponding bands are not 
sharp retarded bands due to the positive charged arginine residues in the FMRP RGG 
box. We therefore mainly monitor the binding event by the disappearance of the band 
corresponding to the free Shank1b RNA, which was further reduced at 1:2 ratio Shank1b 
RNA to FMRP RGG (Figure 4.7 lanes 3 and 7). At the highest FMRP RGG box 
concentration, 1:4 ratio Shank1b to FMRP RGG (Figure 4.7 lanes 4 and 8), the free RNA 
bands have further disappeared while the concomitant diffuse retarded bands 
corresponding to the Shank1b RNA-FMRP RGG complex show the highest intensity. 
The EMSA results indicate that the Shank1b RNA G-quadruplex interacts with the 
FMRP RGG box. Its binding affinity to the FMRP RGG box, however, is not as high as 
that of the Shank1a RNA G-quadruplex accordingly to these results per se, since the free 
Shank1a RNA band disappeared completely at a FMRP RGG box at 1:2 ratio RNA: RGG 
(compare Figure 4.1 lanes 3 and 6 with Figure 4.7 lanes 3 and 7). 
                          
Figure 4.8 The CD spectra of 10 μM Shank1b RNA at various RNA: RGG ratios 
prepared in 10 mM cacodylic acid with 25 mM KCl. It shows that the FMRP RGG 
box induces the unwinding of the Shank1b RNA G-quadruplex at high RNA: RGG 
ratios. 
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 Next, we performed CD spectroscopy to investigate the effect of the FMRP RGG 
box on inducing the unwinding of the Shank1b RNA G-quadruplex. At 0 mM KCl, the 
free Shank1b RNA showed the parallel G-quadruplex CD signature (Figure 4.8 grey 
spectrum). The addition of FMRP RGG box at ratios of 1:1, 1:2 and 1:4 RNA: RGG 
(Figure 4.8 green, orange and red spectra) started to reduce the intensity of the positive 
band at 265 nm. At high FMRP RGG ratios of 1:6 and 1:8 (Figure 4.8 purple and blue 
spectra), the intensity of negative band at 240 nm along with the positive one was 
significantly reduced, suggesting that the FMRP RGG box induces the unwinding of the 
Shank1b RNA G-quadruplex,.  
 Using fluorescence spectroscopy, we aimed to obtain quantitative information 
about the interactions between Shank1b G-quadruplex and the FMRP RGG box. A 
fluorescently labeled Shank1b RNA was constructed by replacing one of the adenines at 
                                
 
Figure 4.9 Two fluorescently labeled Shank1b RNAs were created by replacing the 
adenine at position 5 and position 24 respectively with its fluorescent analog 2-amino 
purine (2AP). 
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position 5 with its fluorescent analog 2-aminopurine (Figure 4.9). Being part of the 
longer loop surrounding the G-quadruplex, this inserted fluorophore was predicted to 
report the binding activity by directly contacting the FMRP RGG box as what observed 
in 2AP labeled Shank1a RNA binding with the RGG box. However, upon monitoring its 
emission wavelength at 371 nm after titrating the FMRP RGG peptides into this 
fluorescent Shank1b RNA, we didn’t observe any significant change of the steady-state 
fluorescence signal (data not shown). From our prior experience, selecting the position of 
the adenine to be replaced by 2AP labeled one has been a challenge when it comes to a 
sequence containing multiple adenines in its G-quadruplex structure, due to the difficulty 
to accurately predict which adenine is directly involved in the binding event. In the case 
of Shank1b RNA, if the longer loop in which the replaced adenine 5 is located is not the 
contact face with the RGG box, the introduced fluorophore will not report the binding 
activity accordingly. Based on the binding event observed from EMSA and CD 
spectroscopy, we are convinced that Shank1b RNA binds to the FMRP RGG. 
Accordingly, we next constructed another 2AP labeled Shank1b RNA by replacing the 
adenine 24 located in the short loop (Figure 4.9), which is predicted to be the alternative 
contact face to FMRP RGG box. The investigation of its binding affinity with FMRP is 
still in progress. 
We started with our hypothesis that the interaction of Shank1 mRNA with FMRP 
occurs in a G-quadruplex dependent manner. Two G-rich sequences were identified and 
predicted to form G-quadruplex in Shank1 mRNA. The results have shown that both G-
quadruplex forming sequences, Shank1a mRNA and Shank1b mRNA, form very stable 
parallel G-quadruplex structures intramolecularly, whereas Shank1a mRNA tends to 
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adopt a more stable structure at the same condition. In terms of interacting with FMRP, 
Shank1a mRNA G-quadruplex binds to the FMRP RGG box and the two FMRP isoforms, 
ISO1 and ISOP. Interestingly, we found that Shank1a mRNA has similar binding affinity 
to ISO1 and its phosphorylated mimic ISOP. It fails to support the assumption that 
phosphorylated FMRP represses the mRNA translation by weakening the binding affinity 
to its mRNA targets. The other selected G-quadruplex forming sequence Shank1b mRNA 
also shows the binding affinity to the FMRP RGG box, though it’s slightly weaker than 
Shank1a mRNA reflected by EMSA. Taken together, the results have shown that 
multiple G-quadruplex RNA motifs exist in the 3’ UTR of human Shank1 mRNA, which 
are required to facilitate its interaction with FMRP. This is consistent with the previous 
finding that FMRP represses Shank1 expression via its 3’ UTR (37). In summary, the 
interaction of FMRP with Shank1 mRNA 3’ UTR is dependent upon the recognition of 
G-quadruplex structure. 
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CHAPTER 5: CHARACTERIZATION OF THE BASP1 RNA G-QUADRUPLEX 
STRUCTURE AND THEIR INTERACTION WITH FMRP 
5.1 Characterization of the BASP1-5’ UTR RNA 
 BASP1 mRNA encodes for the brain abundant, membrane attached signal protein 
1 (BASP1). It was identified as a potential FMRP mRNA target and predicted to form an 
intramolecular G-quadruplex recognized by FMRP RGG box (17). Two sequences 
having high potential to form a G-quadruplex structure in human BASP1 RNA were 
selected based on the prediction by the QGRS mapper, and named in this study BASP1-
     
 
Figure 5.1 The 1H NMR spectra of the BASP1-5’UTR RNA shows the existence of 
the G-quadruplex structure reflected by the imino proton resonances from 10 – 12 ppm 
along with the duplex structure demonstrated by the Watson-Crick base pair 
resonances from 12 – 14 ppm.  
 
0 mM KCl 
10 mM KCl 
25 mM KCl 
50 mM KCl 
150 mM KCl 
150 mM KCl annealed 
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5’ UTR and BASP1-Coding RNA, respectively. First, we performed the analysis of the 
BASP1-5’ UTR RNA, one of the selected G-quadruplex forming sequence in BASP1 
RNA. To examine the existence of the G-quadruplex structure in the BASP1-5’ UTR 
RNA, we employed 1H NMR spectroscopy, monitoring the imino proton resonance 
region. We observed imino proton resonances in the region of 10-12 ppm, indicating the 
G-quadruplex formation in this sequence, even in the absence of KCl (Figure 5.1, blue 
spectrum). Resonances are also present in the region 12 - 14 ppm, originating from 
guanine and uracil imino protons engaged in Watson-Crick base pairs, indicating the 
formation of a duplex structure in the BASP1-5’ UTR RNA. The intensity of the Waston-
Crick imino proton resonances was reduced as the KCl concentration increased, but these 
resonances were present even after the sample was annealed in the presence of 150 mM 
KCl. Taken together, the 1H NMR experiments demonstrate that a G-quadruplex and 
duplex structure coexist in the BASP-5’UTR even at high KCl concentrations. 
 Next, to obtain information about the fold of the G-quadruplex structure formed 
by the BASP-5’UTR we performed CD spectroscopy in the presence of various 
concentrations of KCl. A typical CD spectrum of a B-form DNA duplex structure has a 
positive band on an envelope from 260 – 280 nm and a negative one at 245 nm (57), 
whereas a positive band at 265 nm and a negative one at 240 nm is the typical signature 
of a parallel G-quadruplex (27, 28). At 0 mM KCl (Figure 5.2 orange spectrum), we 
observed a position band at 268 nm and a negative one on a broad envelop from 235 – 
245 nm, indicating a hybrid between duplex and a parallel G-quadruplex structure. Once 
the KCl concentration was increased to 10 mM (Figure 5.2 green spectrum), the 
intensities of both the positive and negative bands increased significantly along with a 
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shift of, the positive one from 268 nm to 265 nm and the negative one to 240 nm. It 
suggests that KCl facilitates the stabilization of the G-quadruplex structure in the BASP1-
5’UTR RNA as it co-exists with duplex. At higher concentrations 25, 50 and 100 mM 
(Figure 5.2 blue, red and purple spectra), the intensities of both bands further increased, 
but not as much as from 0 mM to 25 mM KCl. Taken together the 1H NMR spectroscopy 
and CD spectroscopy, indicate that BASP1-5’UTR adopts a parallel G-quadruplex and a 
duplex structure, both of them co-existing at higher concentration of KCl while the G-
quadruplex is further stabilized by the presence of K+ ions. 
 
 To examine the conformation change of the G-quadruplex formed in the BASP1-
5’UTR RNA, we performed UV thermal denaturation experiments. 10 μM of BASP1-5’ 
UTR RNA in 10 mM cacodylic acid, pH 6.5, was thermally denatured at different 
conditions, as the absorbance was monitored at 295 nm that has been shown to be most 
                             
 
Figure 5.2 The CD spectra of 10 μM BASP1-5’UTR RNA prepared in 10 mM 
cacodylic acid at various KCl concentrations shows a parallel G-quadruplex structures 
stabilized by KCl. 
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sensitive to G-quadruplex dissociation (30). In the absence of KCl (Figure 5.3 red 
spectrum), we observed a major transition and a minor one separated at 35 °C. Once the 
KCl concentration was increased to 10 mM (Figure 5.3 green spectrum), a hypochromic 
transition corresponding to the G-quadruplex dissociation was observed from 40 – 75 °C, 
indicating that KCl enhances the stability of G-quadruplex in the BASP1-5’UTR RNA. 
At 25 mM KCl (Figure 5.3 blue spectrum), this hypochromic transition slightly shifted 
towards high temperature, suggesting that KCl further facilitates its stabilization. 
Accordingly, the minor transition from 0 – 40 °C in the presence of KCl was assigned to 
be the duplex dissociation due to its less stable structure. In the absence of KCl, the major 
transition from 35 – 50 °C corresponds to the G-quadruplex dissociation without effect of 
K+ ions. Clearly, its stability was reduced in the absence of KCl. Taken together the CD 
spectroscopy and the UV thermal denaturation, demonstrate that BASP1-5’ UTR forms 
G-quadruplex and duplex, the latter is further stabilized by the presence of K+ ions. 
                        
Figure 5.3 The UV thermal denaturation profiles of 10 μM BASP1-5’UTR RNA 
prepared in 10 mM cacodylic acid at different conditions. It shows a hypochromic 
transitions 40 - 75 °C indicating the G-quadruplex dissociation along with the 
coexistence of duplex dissociation 0 – 10 °C. 
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5.2 Characterization of the BASP1-Coding RNA 
 After identifying the existence of G-quadruplex structure in the BASP1-5’UTR 
RNA, we analyzed the other G-quadruplex forming sequence in BASP1 RNA, BASP1-
Coding RNA. We first performed 1H-NMR spectroscopy to examine the G-quadruplex 
existence in the BASP1-Coding RNA, monitoring the imino proton resonance region. 
Spectra were acquired for the BASP1-Coding RNA sample in the presence of different 
concentrations of KCl. In the absence of KCl (Figure 5.4 blue spectrum), we observed 
imino proton resonances from 10 – 12 ppm on a very broad envelope, indicating that the 
     
 
Figure 5.4 The 1H NMR spectra of the BASP1-Coding RNA shows the existence of 
the G-quadruplex structure reflected by the imino proton resonances from 10 – 12 ppm 
along with the duplex structure demonstrated by the Watson-Crick base pair 
resonances from 12 – 14 ppm. The G-quadruplex formation is stabilized by adding 
KCl and annealing the RNA. 
 
0 mM KCl 
10 mM KCl 
150 mM KCl 
150 mM KCl 
annealed 
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BASP1-Coding RNA forms a G-quadruplex structure though it’s less stable than the 
BASP1-5’ UTR G-quadruplex at the same condition (Figure 5.1 blue spectrum). Very 
refined resonances located between 12 -14 ppm report upon guanine and uracil imino 
protons involved in Watson-Crick base-pairs, indicating that BASP1-Coding RNA forms 
a duplex structure as well. The intensity of the imino proton resonances located in 10 – 
12 ppm was increased as the KCl concentration increased, while the Waston-Crick imino 
proton resonances were present throughout the various concentrations of KCl (Figure 5.4, 
red, green and purple spectra), suggesting that G-quaduplex and duplex co-exists in the 
BASP1-Coding RNA even at the high concentration of KCl, G-quadruplex is further 
stabilized by the presence of K+ ions. 
5.3 Characterization of the interactions between the BASP1 RNAs and FMRP 
 After identifying the existence of G-quadruplex in the BASP1-5’ UTR and 
BASP1-Coding RNA, we characterized their interaction with the FMRP RGG box by 
employing electromobility gel shift assay and fluorescence spectroscopy. EMSA showed 
no binding affinity between these two G-quadruplex forming RNAs and the FMRP RGG 
box at various RNA: RGG ratios (data not shown). To confirm the EMSA results, we 
constructed the fluorescent variants of BASP1-5’UTR and BASP1-Coding RNA by 
replacing one of the adenines in each RNA by its fluorescent analog 2-aminopurine. We 
didn’t observe significant fluorescence intensity change by titrating the FMRP RGG 
peptides into the 2AP labeled RNAs (data not shown), confirming that BASP1-5’ UTR 
and BASP1-Coding RNA G-quadruplexes do not interact with the FMRP RGG box. 
Since the binding domain RGG box shows no binding affinity with these two G-
quadruplex forming RNAs, we didn’t inquire their binding affinity with the full-length 
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FMRP isoforms. Taken together EMSA and fluorescence spectroscopy, indicate that even 
though these selected sequences in the BASP1 RNA adopts G-quadruplex structure, this 
secondary RNA structure per se is not sufficient to facilitate the interaction of the BASP1 
RNA with the FMRP. The interaction of BASP1 mRNA with FMRP may be mainly 
determined by other structural elements. 
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CHAPTER 6: CONCLUSIONS 
6.1 Characterization of G-quadruplex formation within G-rich sequences in Shank1 
mRNA 
We started with the hypothesis that the interaction of Shank1 mRNA with FMRP 
is dependent on a G-quadruplex structure. Therefore, we first identified two G-rich 
sequences within the Shank1 mRNA and named Shank1a and Shank1b RNA in this 
study. The results show the existence of G-quadruplex structure in Shank1a and Shank1b 
RNA even in the absence of KCl. There are alternate G-quadruplex conformations 
existing in both of Shank1a and Shank1b RNA, one of which is further stabilized by the 
presence of K+ ions. Both G-rich sequences forms a very stable parallel and 
intramolecular G-quadruplex whereas Shank1a RNA G-quadruplex tends to be more 
stable at the same condition.  
6.2 Characterization of the G-rich sequences of Shank1 mRNA interacting with 
FMRP 
To examine the interaction of Shank1 mRNA with FMRP, we have quantitatively 
determined the binding affinity of the G-quadruplex-forming sequence Shank1a RNA to 
the FMRP RGG box and to two full-length FMRP isoforms. The results show a high 
binding affinity of the Shank1a RNA to the FMRP RGG box and a slightly reduced 
binding affinity to the FMRP isoforms due to the structural complexity of the full-length 
protein and therefore the reduced accessibility to the RGG box. The other G-quadruplex 
forming sequence Shank1b mRNA also binds to the FMRP RGG box though its binding 
affinity is not as tight as Shank1a mRNA. These results have been consistent with the 
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previous findings that FMRP interacts with Shank1 mRNA via its 3’ UTR (37). 
Furthermore, it indicates that the interaction occurs at these G-quadruplex forming sites, 
of which recognition by FMRP is dependent on the G-quadruplex RNA motif. 
Previous findings have shown that unphosphorylated FMRP is associated with 
actively translating polyribosomes while the phosphorylated form interacts with stalled 
ribosomes, suggesting a role of phosphorylation in modulating the translation regulation 
function of FMRP (16). Accordingly, we assumed that the phosphorylated form of FMRP 
represses the gene translation by negatively influence its binding affinity to mRNA 
targets. It has been shown that FMRP represses translation of Shank1 mRNA via its 3’ 
UTR (37). Furthermore, our results show that the G-quadruplex RNA motifs located in 
the Shank1 mRNA 3’ UTR are required to facilitate its interaction with FMRP. If FMRP 
phosphorylation regulates the translation of Shank1 mRNA by simply varying the 
binding affinity to its mRNA target, different binding activity is expected between the 
phosphorylated FMRP and the dephosphorylated form. Interestingly, the Shank1a RNA 
has shown no difference in terms of binding to the full-length FMRP isoform ISO1 and 
its phosphorylated mutant ISOP. It suggests that the posttranslational modification of 
phosphorylation does not modulate the translation regulator function of FMRP through 
different binding affinity to its G-quadruplex forming target Shank1a RNA, however, it 
may be important in other aspects of FMRP regulating the mRNA translation involving 
other pathways. Likely, one of the involvements is miRNA. 
MicroRNAs (miRNAs) are short noncoding RNAs (~22 nucleotide) that control 
translation of specific target mRNAs by complementing with antisense sequences in the 
3' UTR of these mRNAs to inhibit their translation or promote their decay (58-61). 
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FMRP is biochemically and genetically linked to the miRNA pathway (10). Specifically, 
the miRNA interacts with FMRP, functioning as translational repressor. It has been 
shown that miR-125b and miR-132, as well as several other miRNAs, are associated with 
FMRP in mouse brain (10). It has been shown that one of the miRNA targets, NMDA 
receptor subunit NR2A, is negatively regulated through its 3’ UTR by FMRP 
collaborating with miR-125b in hippocampal neurons (10). 
The significance of this study is to serve as the molecular groundwork to 
investigate the mechanism of how FMRP regulates the gene expression by controlling its 
mRNAs translation and how the absence of FMRP may disrupt this regulatory process. 
Particularly, by identifying the G-quadruplex structure in the 3’ UTR of Shank1 mRNA 
and its interaction with FMRP, we provided a FMRP recognition site in Shank1 mRNA 
that potentially interact with miRNA. Considering the role of miRNA pathways in FMRP 
functioning as a translation regulator, we reason that FMRP may alternatively regulate 
the translation of its target Shank1 mRNA via miRNA involvement. Taken together, it 
contributes to the investigation on the function of FMRP in fragile X syndrome, and 
furthermore, the molecular pathogenesis of fragile X syndrome and potential therapeutic 
targets. 
6.3 Characterization of the G-quadruplex formation within G-rich sequences of the 
BASP1 mRNA 
Two G-rich sequences were identified within BASP1 mRNA and named as 
BASP1-5’ UTR and BASP1-Coding RNA according to the regions they are located in. 
The results show a G-quadruplex structure exists in both sequences along with a duplex 
structure while the former is stabilized by the presence of K+ ions. Both of BASP1-5’ 
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UTR and BASP1-Coding RNA intramolecularly form a parallel G-quadruplex structure, 
which have been hypothesized to interact with FMRP. The EMSA and fluorescence 
spectroscopy have shown, however, these two G-quadruplex forming sequences lack the 
binding affinity to the FMRP RGG box. Even though the previous findings have shown 
that BASP1 mRNA is an in vivo target of FMRP (17), our results fails to support the 
prediction that G-rich regions in BASP1 mRNA are the recognition sites by FMRP RGG 
box. It suggests that G-quadruplex RNA motif may be required, but not sufficient to 
facilitate the interaction between BASP1 mRNA and FMRP per se, which may be 
determined by other structural elements.  
6.4 Future direction 
As previously mentioned, it’s important to rationalize the role of posttranslational 
modification of phosphorylation in the translation regulator function of FMRP. 
Accordingly, we aim to investigate the binding event between the other G-quadruplex 
forming sequence Shank1b and two FMRP isoforms. If the observation shows no binding 
affinity difference of Shank1b mRNA to ISO1 and its phosphorylated form ISOP, it 
indicates a consensus between these two G-rich regions. This analysis will be helpful to 
illustrate if FMRP phosphorylation modulates its translation regulator function by 
altering its binding affinity to its G-quadruplex forming target Shank1 mRNA. 
We have identified miRNAs associated with FMRP in mouse brain that are also 
complementing with G-quadruplex forming sequences in Shank1 mRNA. To analyze if 
miRNAs play a role in FMRP regulating Shank1 mRNA translation at these G-
quadruplex forming site, it will be necessary to investigate the interaction among FMRP, 
Shank1 mRNA and miRNAs by employing biophysical and biochemical methods. This 
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provides potential information that are important to answer (i) if FMRP regulating 
Shank1 mRNA translation is modulated by miRNAs (ii) if FMRP phosphorylation 
functioning in repressing Shank1 expression is dependent on the involvement of miRNAs 
and (iii) how does the absence of FMRP disrupt this regulatory process in FXS. 
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